Kulkarni Samarth sold CRSP
October 19, 2026 · Form 4 insider transaction
Kulkarni Samarth sold 47,837 shares of CRISPR Therapeutics AG at $49.78 per share, a transaction worth $2.38M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
47,837
Price
$49.78
Total value
$2.38M
InsiderKulkarni Samarth
RoleOfficer, Director
SecurityCommon Shares
Transaction codeS: Open-market sale
Transaction dateOctober 19, 2026
Filing dateOctober 20, 2026
Shares owned after311,899
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.